Ranger Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
Ranger Investment Management's NEO Position: Q2 2022 in Review
Ranger Investment Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 776,428 shares — an estimated $9.43M sold.
Ranger Investment Management first reported a position in NEO in Q3 2017 and held it in 19 quarters. The position peaked at $50.7M in Q4 2020. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.
- Ranger Investment Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
- Ranger Investment Management sold 776,428 NeoGenomics shares in Q2 2022, an estimated $9.43M.
- Ranger Investment Management first reported a position in NeoGenomics in Q3 2017 and held it in 19 quarters.
- Ranger Investment Management's NeoGenomics position peaked at $50.7M in Q4 2020.
- 240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.
Based on Ranger Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.